Loading
Tryptophan and Brain Disorders / Treatment of Major Depression / Bipolar Disorder and Treatment · Journal article
Mood and Emotion · July 31, 2026
A consensus or society position rather than new primary data.
This narrative review identifies established clinical features (early onset, recurrence, family history, mixed features, antidepressant-induced switching, treatment resistance) and emerging biomarker approaches (neuroimaging, electrophysiology, circadian assessment, peripheral biomarkers, digital phenotyping, machine learning) that may improve diagnostic discrimination between bipolar and unipolar depression. However, the authors explicitly state no single marker is suitable for routine clinical use, and they recommend a longitudinal, probabilistic, multimodal framework rather than endorsing any specific diagnostic test.
Journal article. Patients with bipolar and unipolar depression presenting during depressive episodes.
Bipolar and unipolar depression share substantial clinical overlap, leading to frequent misdiagnosis of bipolar disorder as major depressive disorder Established clinical indicators include early age at onset, recurrent depressive episodes, family history of bipolar disorder, mixed features, antidepressant-induced mood switching, and treatment resistance Emerging evidence from neuroimaging, electrophysiology, circadian rhythm evaluation, peripheral biomarkers, digital phenotyping, and machine-learning approaches suggests multimodal integration may improve diagnostic precision
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
Clinicians should integrate established clinical features with emerging multimodal biomarkers in a longitudinal framework to improve early recognition of bipolarity and reduce misdiagnosis. However, no specific test or marker yet supports standalone diagnostic use in routine practice.
A narrative review synthesizing clinical, biological, and digital evidence on diagnostic differentiation; proposes a multimodal framework but acknowledges no single marker is suitable for routine clinical use, reflecting guidance rather than definitive clinical trial evidence.
Clinicians should integrate established clinical features with emerging multimodal biomarkers in a longitudinal framework to improve early recognition of bipolarity and reduce misdiagnosis. However, no specific test or marker yet supports standalone diagnostic use in routine practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
Bipolar and unipolar depression share substantial clinical overlap, making differential diagnosis during depressive episodes particularly challenging.Because current diagnostic systems rely on the retrospective identification of manic or hypomanic episodes, many patients with bipolar disorder are initially misdiagnosed with major depressive disorder, resulting in delayed diagnosis, inappropriate antidepressant treatment, mood destabilization, and poorer outcomes.This review summarizes current evidence on clinical, biological, and digital approaches to differentiating bipolar from unipolar depression.Established clinical indicators-including early age at onset, recurrent depressive episodes, family history of bipolar disorder, mixed features, antidepressant-induced mood switching, and treatment resistanceremain central to diagnostic assessment.Emerging evidence from neuroimaging, electrophysiology, circadian rhythm evaluation, peripheral biomarkers, digital phenotyping, and machine-learning approaches suggests that multimodal integration may improve diagnostic precision.Although no single marker is suitable for routine clinical use, a longitudinal, probabilistic, and multimodal framework may facilitate earlier recognition of bipolarity and more personalized treatment strategies.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.